As­traZeneca nabs 6 more months for Sym­bi­cort patent in lat­est court rul­ing

A fed­er­al judge in West Vir­ginia ruled in fa­vor of As­traZeneca on Wednes­day, adding six months of patent pro­tec­tion for its asth­ma and COPD in­haler …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.